Analyst Reco. Hims & Hers Health, Inc.

Equities

HIMS

US4330001060

Real-time Estimate Cboe BZX Other stock markets 15:24:41 29/04/2024 BST			5-day change	1st Jan Change
12.72 ^USD	+1.76%		+6.31%	+41.91%

04-26	Seaport Global Starts Hims & Hers Health With Buy Rating	MT
04-16	Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Seaport Global Starts Hims & Hers Health With Buy Rating	04-26	MT
Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17	04-16	MT
Canaccord Genuity Initiates Coverage on Hims & Hers Health With Buy Rating, $20 Price Target	04-10	MT
Hims & Hers Health Insider Sold Shares Worth $823,055, According to a Recent SEC Filing	03-22	MT
Tigress Financial Boosts Price Target on Hims & Hers Health to $19 From $15, Cites Move to Accelerated Growth Phase, Keeps Buy Rating	03-01	MT
Piper Sandler Adjusts Price Target on Hims & Hers Health to $11 From $9, Maintains Neutral Rating	02-27	MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $14 From $8, Maintains Hold Rating	02-27	MT
Truist Securities Adjusts Price Target on Hims & Hers Health to $13 From $10, Keeps Hold Rating	02-27	MT
Leerink Partners Initiates Coverage on Hims & Hers Health With Market Perform Rating, $10 Price Target	02-26	MT
Tigress Financial Raises Price Target on Hims & Hers Health to $15 From $14, Maintains Buy Rating	01-05	MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $8 From $11, Maintains Hold Rating	11-08	MT
Truist Securities Cuts Price Target on Hims & Hers Health to $10 From $12, Maintains Hold Rating	09/08/23	MT
TD Cowen Starts Hims & Hers Health at Outperform With $11 Price Target	28/07/23	MT
Tigress Financial Adjusts Hims & Hers Health Price Target to $14 From $12 Due to Ongoing Growth, Penetration in Core Markets, Maintains Buy Rating	15/06/23	MT
Tigress Financial Adjusts Hims & Hers Health Price Target to $14 From $12, Maintains Buy Rating	15/06/23	MT
Piper Sandler Adjusts Price Target on Hims & Hers Health to $11 From $12, Keeps Neutral Rating	30/05/23	MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $11 From $9, Maintains Hold Rating	10/05/23	MT
BofA Securities Adjusts Hims & Hers Health's Price Target to $15 From $13.50, Keeps Buy Rating	09/05/23	MT
Piper Sandler Adjusts Price Target on Hims & Hers Health to $12 From $10, Keeps Neutral Rating	09/05/23	MT
Guggenheim Adjusts Price Target on Hims & Hers Health to $18 From $15, Maintains Buy Rating	27/04/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Hims & Hers Health, Inc.

Equities

HIMS

US4330001060

Analyst Reco.

Filters